Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
AEMD Aethlon Medical, Inc. daily Stock Chart
AEMD [NASD]
Aethlon Medical, Inc.
Technology | Scientific & Technical Instruments | USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.34 Insider Own3.70% Shs Outstand18.21M Perf Week-0.57%
Market Cap4.73M Forward P/E- EPS next Y-0.20 Insider Trans0.00% Shs Float17.82M Perf Month-17.28%
Income-6.20M PEG- EPS next Q-0.07 Inst Own14.80% Short Float1.37% Perf Quarter-38.10%
Sales0.20M P/S23.67 EPS this Y25.90% Inst Trans-3.30% Short Ratio1.07 Perf Half Y-74.25%
Book/sh0.06 P/B4.33 EPS next Y25.90% ROA- Target Price3.00 Perf Year-76.36%
Cash/sh0.14 P/C1.89 EPS next 5Y- ROE- 52W Range0.20 - 1.74 Perf YTD-84.34%
Dividend- P/FCF- EPS past 5Y37.00% ROI-176.40% 52W High-85.06% Beta1.07
Dividend %- Quick Ratio1.50 Sales past 5Y-32.40% Gross Margin- 52W Low28.40% ATR0.03
Employees6 Current Ratio1.50 Sales Q/Q-79.90% Oper. Margin- RSI (14)45.51 Volatility11.55% 15.55%
OptionableNo Debt/Eq0.91 EPS Q/Q- Profit Margin- Rel Volume0.14 Prev Close0.26
ShortableYes LT Debt/Eq0.00 EarningsAug 14 AMC Payout- Avg Volume228.98K Price0.26
Recom2.00 SMA200.89% SMA50-17.01% SMA200-69.18% Volume31,556 Change0.09%
Nov-20-17Initiated H.C. Wainwright Buy $3
Aug-14-19 04:15PM  Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update PR Newswire +12.67%
Aug-07-19 01:36PM  Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 14, 2019 PR Newswire +10.64%
Jul-08-19 10:20AM  AEMD: SeaStar Collaboration Is Intriguing, More Evidence of Exosomes Role in Cancer Progression Zacks Small Cap Research
Jul-01-19 04:15PM  Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update PR Newswire +20.55%
02:30PM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
08:31AM  Aethlon Medical, Inc. and SeaStar Medical, Inc. Announce Strategic Joint Cross-Licensing Agreement PR Newswire
Jun-19-19 02:00PM  Aethlon Medical To Release Fiscal Year End Financial Results and Host Conference Call on July 1, 2019 PR Newswire
May-13-19 08:00AM  Aethlon Medical Announces Collaboration With Prostate On-Site Project (POP), Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies PR Newswire
Apr-17-19 08:27AM  Aethlon Medical Releases Shareholder Update PR Newswire
Apr-05-19 12:31PM  How Financially Strong Is Aethlon Medical, Inc. (NASDAQ:AEMD)? Simply Wall St.
Mar-07-19 08:47AM  Aethlon Medical, Inc. Announces Appointment of Lisa M. Boswell as Director, Quality Systems and Regulatory Affairs PR Newswire
Feb-13-19 03:45PM  AEMD: Eventual FDA Cancer Indication Is A Realistic Outcome Zacks Small Cap Research -21.67%
Feb-11-19 04:15PM  Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update PR Newswire
02:30PM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Feb-04-19 02:49PM  Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on February 11, 2019 PR Newswire
Jan-18-19 07:35AM  Market Trends Toward New Normal in Roper Technologies, The AES, D.R. Horton, Forrester Research, Aethlon Medical, and CyberOptics Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Dec-13-18 08:29AM  Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer PR Newswire
Nov-28-18 06:50AM  Todays Research Reports on Stocks to Watch: Arsanis and Aethlon Medical ACCESSWIRE
Nov-27-18 01:30PM  AEMD: Breakthrough Device Designation Granted for Cancer Therapy. Could Be Game-Changer for AEMD Zacks Small Cap Research +25.64%
10:10AM  The Reason Healthcare Stocks Are Being Called Home By Investors ACCESSWIRE
07:21AM  Aethlon Medical's Cancer Therapy Receives "Breakthrough Device" Designation from the U.S. Food and Drug Administration PR Newswire
Nov-12-18 09:45AM  AEMD: Pivot Towards Cancer Makes Sense. FDA Filing For Breakthrough Device in Cancer Zacks Small Cap Research
08:15AM  Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Nov-06-18 04:15PM  Aethlon Medical Announces Second Quarter Fiscal Year 2019 Results PR Newswire
Nov-01-18 08:30AM  Aethlon Medical To Release Quarterly Financial Results and Host Conference Call on November 6, 2018 PR Newswire
Oct-29-18 11:59AM  Aethlon Medical to Present at the NYC Oncology Conference PR Newswire
Oct-18-18 09:25AM  Investor Expectations to Drive Momentum within Aethlon Medical, Jaguar Animal Health, Advaxis, Forestar Group, Platform Specialty Products, and AVEO Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Oct-16-18 08:15AM  Aethlon Medical to Present at the 2018 BIO Investor Forum PR Newswire
Oct-09-18 01:06PM  How Financially Strong Is Aethlon Medical Inc (NASDAQ:AEMD)? Simply Wall St.
Sep-18-18 08:46AM  Aethlon Medical Receives National Cancer Institute Award PR Newswire
Aug-28-18 09:15AM  AEMD: Compassionate Use, Real-World Data, Awaiting FDA Final Guidance Zacks Small Cap Research
Aug-27-18 08:00AM  Research Report Identifies Ball, Aethlon Medical, NeoGenomics, Del Taco Restaurants, Arconic, and Agilysys with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Aug-08-18 04:15PM  Aethlon Medical Announces First Quarter Fiscal Year 2019 Results PR Newswire
02:30PM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:15AM  Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2019 and Host Conference Call on August 8, 2018 PR Newswire
Jun-27-18 09:15AM  Loss-Making Aethlon Medical Inc (NASDAQ:AEMD) Expected To Breakeven Simply Wall St.
Jun-25-18 09:15AM  Guy Cipriani Joins Aethlon Medical's Board of Directors PR Newswire
Jun-21-18 07:55AM  New Research: Key Drivers of Growth for Nicolet Bankshares, Vitamin Shoppe, Aethlon Medical, Barrett Business Services, Veracyte, and TPG Specialty Lending Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Jun-13-18 09:30AM  AEMD: AEMD In Active Discussions With FDA Regarding Hemopurifier Pathway Zacks Small Cap Research
Jun-08-18 04:15PM  Aethlon Medical Announces Fiscal 2018 Results PR Newswire +5.38%
May-31-18 08:45AM  Aethlon Medical To Release 2018 Fiscal Year End Financial Results and Host Conference Call on June 8, 2018 PR Newswire
May-25-18 10:49AM  Are Aethlon Medical Incs (NASDAQ:AEMD) Interest Costs Too High? Simply Wall St.
May-01-18 07:55AM  Report: Developing Opportunities within AMC Networks, JELD-WEN Holding, Blueprint Medicines, Northwest Bancshares, Anika Therapeutics, and Aethlon Medical Future Expectations, Projections Moving into 2018 GlobeNewswire
Apr-20-18 01:00PM  GVC Capital and Trickle Research Announce Presenter Schedule for Rocky Mountain MicroCap Conference II in Denver on April 24, 2018 ACCESSWIRE
Mar-22-18 08:00AM  Study of Blood Test to Detect and Monitor Chronic Traumatic Encephalopathy (CTE) in Former NFL Players Set for Kick-Off in Phoenix PR Newswire -7.09%
Mar-19-18 08:25AM  Research Report Identifies Chatham Lodging Trust (REIT), Independent Bank Group, NeoGenomics, Black Knight, Aethlon Medical, and PRA Group with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -11.05%
Feb-12-18 06:32AM  Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting PR Newswire +6.94%
Feb-06-18 10:00AM  AEMD: Q3 Results. Hemopurifier Pathway Could Benefit From New FDA Mindset Zacks Small Cap Research +9.28%
Feb-01-18 04:15PM  Aethlon Medical Announces Fiscal 2018 Third Quarter Results PR Newswire
Jan-29-18 08:15AM  Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018 PR Newswire +6.79%
Jan-23-18 08:15AM  Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes PR Newswire
Jan-19-18 06:05PM  Is It The Right Time To Buy Aethlon Medical Inc (NASDAQ:AEMD)? Simply Wall St.
Jan-18-18 07:49AM  Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections PR Newswire
Jan-17-18 08:15AM  Market Trends Toward New Normal in FTD Companies, Acuity Brands, MINDBODY, Actinium Pharmaceuticals, XG Technology, and Aethlon Medical Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Jan-10-18 09:01AM  Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors PR Newswire
Jan-07-18 04:18PM  Aethlon Shares Jump Before '60 Minutes' Report On CTE, Vets Benzinga
Dec-27-17 07:55PM  How Does Aethlon Medical Incs (NASDAQ:AEMD) Earnings Growth Stack Up Against Industry Performance? Simply Wall St.
Nov-29-17 07:45AM  Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board PR Newswire
Nov-21-17 10:49AM  What Investors Should Know About Aethlon Medical Incs (AEMD) Financial Strength Simply Wall St.
Nov-09-17 12:58PM  Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors PR Newswire +10.82%
Nov-08-17 12:00PM  AEMD: Upcoming FDA Meeting Expected to Define U.S. Regulatory Pathway Zacks Small Cap Research -5.99%
Nov-02-17 04:15PM  Aethlon Medical Announces Fiscal 2018 Second Quarter Results PR Newswire
11:00AM  Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Oct-30-17 07:30AM  Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017 PR Newswire
Oct-23-17 08:00AM  AEMD: NCI Cancer Grant, FDAs Real World Data Zacks Small Cap Research
Oct-18-17 07:00AM  Featured Company News - iBio Announces Large-Scale Manufacturing Collaboration with Aethlon Medical ACCESSWIRE
Oct-16-17 07:15AM  iBio Announces Manufacturing Collaboration with Aethlon Medical GlobeNewswire
07:15AM  Aethlon Medical Announces Large-Scale Production Collaboration PR Newswire
Oct-12-17 10:14AM  How Does Aethlon Medical Inc (AEMD)s Prospect Stack Up Next To Its Healthcare Peers? Simply Wall St.
Oct-11-17 08:15AM  Aethlon Medical to Present at the 2017 BIO Investor Forum PR Newswire
Oct-10-17 01:27PM  Aethlon Medical Announces Compliance With Nasdaq Listing Criteria PR Newswire
Oct-02-17 06:00AM  Aethlon Medical Announces Pricing of $6 Million Public Offering PR Newswire -37.66%
Sep-14-17 07:30AM  Aethlon Medical Receives National Cancer Institute Contract Award PR Newswire
Sep-13-17 08:20AM  Today's Research Reports on Stocks to Watch: Aldeyra Therapeutics and Aethlon Medical ACCESSWIRE -12.22%
Sep-12-17 07:30AM  Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses PR Newswire +35.13%
Sep-11-17 08:51PM  Should You Have Aethlon Medical Incs (AEMD) In Your Portfolio? Simply Wall St. +25.67%
Sep-06-17 09:12AM  Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017 PR Newswire +7.38%
Aug-21-17 10:00AM  AEMD: EAP Filed, Expect FDA Response By Mid-September Zacks Small Cap Research
Aug-11-17 09:02AM  Former NFL Pro Supports Study Of Brain Injuries And Dementia In Football Forbes
Aug-10-17 04:15PM  Aethlon Medical Announces Fiscal 2018 First Quarter Results PR Newswire
01:00PM  Investor Network: Aethlon Medical, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 07:29PM  ETFs with exposure to Aethlon Medical, Inc. : August 3, 2017 Capital Cube
08:00AM  Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017 PR Newswire
Jul-19-17 07:11AM  Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes PR Newswire
Jul-07-17 07:00AM  Corporate News Blog - MedShape Divests its ExoShape(R) ACL Product Line to CONMED Accesswire
Jul-03-17 02:46PM  ETFs with exposure to Aethlon Medical, Inc. : July 3, 2017 Capital Cube
Jun-30-17 03:00PM  AEMD: Feasibility Study Validates Capture, EAP FDA Filing Is Next Zacks Small Cap Research
12:50PM  Aethlon Medical, Inc. :AEMD-US: Earnings Analysis: 2017 By the Numbers : June 30, 2017 Capital Cube
Jun-28-17 04:15PM  Aethlon Medical Announces Fiscal 2017 Results PR Newswire
Jun-26-17 08:15AM  Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017 PR Newswire
Jun-14-17 08:00AM  Aethlon Medical To Present Clinical Study Results at The BIO International Convention PR Newswire
Jun-06-17 08:00AM  Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017 PR Newswire
May-24-17 08:00AM  Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017 PR Newswire
Apr-28-17 11:00AM  AEMD: Feasibility Study Complete. FDA Discussions Expected To Follow Zacks Small Cap Research
Apr-24-17 09:25AM  Aethlon Medical Releases Shareholder Update PR Newswire
Apr-04-17 09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio PR Newswire
09:03AM  Aethlon Medical Discloses Tech Nation Interview On National Public Radio
Mar-31-17 09:17AM  AETHLON MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of
Mar-21-17 02:50PM  AETHLON MEDICAL INC Files SEC form 8-K, Other Events
Mar-14-17 05:17PM  AETHLON MEDICAL INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Aethlon Medical, Inc., a medical technology company, focuses on addressing unmet needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. The company is based in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Champion Christopher OSVP, CAO and ControllerJun 01Option Exercise0.001,491014,667Jun 04 04:23 PM
GORDON JOHN RDirectorMay 16Option Exercise45.193,400153,646191,560May 16 05:55 PM
FLUOR PETER JDirectorMay 14Option Exercise45.193,400153,646158,642May 16 06:02 PM
Fink Benjamin MatthewEVP, Finance and CFOFeb 13Option Exercise0.00917020,119Feb 14 05:02 PM
REEVES ROBERT KEVPNov 14Option Exercise0.006,5040133,409Nov 16 05:02 PM
Champion Christopher OSVP, CAO and ControllerNov 14Option Exercise0.002,775013,809Nov 16 04:44 PM
WALKER R AChairman & CEONov 14Option Exercise0.0019,2510236,816Nov 16 04:35 PM
McMillian Amanda M.EVP and General CounselNov 14Option Exercise0.003,469019,615Nov 16 04:31 PM
Ingram Mitchell WEVP, Intl, DW & ExplorationNov 14Option Exercise0.007,718053,746Nov 16 04:27 PM
GWIN ROBERT GPresidentNov 14Option Exercise0.007,718074,243Nov 16 04:23 PM
Brown Daniel EEVP, US Onshore OperationsNov 14Option Exercise0.007,718029,307Nov 16 04:16 PM
WALKER R AChairman, President & CEONov 10Option Exercise0.0014,9510222,946Nov 14 05:29 PM
GWIN ROBERT GEVP, Finance & CFONov 10Option Exercise0.005,994069,357Nov 14 05:22 PM
Champion Christopher OSVP, CAO and ControllerNov 10Option Exercise0.002,020011,499Nov 14 05:17 PM
Brown Daniel EEVP, US Onshore OperationsNov 10Option Exercise0.003,098022,286Nov 14 05:12 PM
REEVES ROBERT KEVP and CAONov 10Option Exercise0.004,6740128,584Nov 14 05:07 PM
McMillian Amanda M.EVP and General CounselNov 10Option Exercise0.002,424016,705Nov 14 05:02 PM
Ingram Mitchell WEVP, Intl, DW & ExplorationNov 10Option Exercise0.005,994048,329Nov 14 04:30 PM
Ingram Mitchell WEVP, Intl, DW & ExplorationNov 01Option Exercise0.0019,936048,842Nov 05 04:33 PM
GWIN ROBERT GEVP, Finance & CFOOct 26Option Exercise0.005,375066,333Oct 30 05:23 PM
McMillian Amanda M.EVP and General CounselOct 26Option Exercise0.001,691014,662Oct 30 05:19 PM
Champion Christopher OSVP, CAO and ControllerOct 26Option Exercise0.001,69109,865Oct 30 05:15 PM
REEVES ROBERT KEVP and CAOOct 26Option Exercise0.004,1910125,512Oct 30 05:11 PM
WALKER R AChairman, President & CEOOct 26Option Exercise0.0013,4030213,118Oct 30 05:05 PM
Brown Daniel EEVP, US Onshore OperationsOct 26Option Exercise0.002,053019,649Oct 30 05:01 PM
open in yahoo | open in reuters | open in google